You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNA Hypomethylating Agent

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

Recruiting
  • Hypomethylating Agent
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue

Withdrawn
  • Castration Levels of Testosterone
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 31, 2021

Acute Myeloid Leukemia, in Relapsed or Refractory, Acute Myeloid Leukemia, Elderly, Unfit, Acute Myeloid Leukemia With Positive

Unknown status
  • Acute Myeloid Leukemia, in Relapsed or Refractory
  • +2 more
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 8, 2020

Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)

Active, not recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Irving Medical Center
Nov 29, 2022

AML, MDS Trial in Houston (Vibecotamab, Dexamethasone, Acetaminophen)

Recruiting
  • AML
  • MDS
  • Houston, Texas
    M D Anderson Cancer Center
Sep 29, 2022

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

MDS Trial in New Haven (CPX-351)

Withdrawn
  • MDS
  • New Haven, Connecticut
    Yale University; Smilow Cancer Center
Jan 6, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia Trial in Los Angeles, Sacramento, Oklahoma City (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Los Angeles, California
  • +2 more
Mar 11, 2022

Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Mesothelioma
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 1, 2023

Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

Completed
  • Refractory Cancer
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Aug 1, 2023

Myelodysplastic Syndrome (MDS) Trial in Cleveland (CPX-351)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Apr 21, 2021

Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Navitoclax
  • +6 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Feb 2, 2023

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Trial in Kashiwa (HRO761,

Recruiting
  • MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
  • Kashiwa, Chiba, Japan
    Novartis Investigative Site
May 2, 2023

Advanced Cancer Trial in Belgium, France (AsiDNA)

Completed
  • Advanced Cancer
  • Bruxelles, Belgium
  • +4 more
Mar 23, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, High Risk

Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +5 more
  • Gemtuzumab Ozogamicin
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • Biopsy
  • +4 more
  • (no location specified)
Jan 4, 2023

Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • Trieste, Italy
    SC Ematologia Ospedale Maggiore
Sep 14, 2020

Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 27, 2022

Small Cell Lung Cancer, Extensive-stage Small Cell Lung Cancer Trial in United States (Guadecitabine, Carboplatin)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extensive-stage Small Cell Lung Cancer
  • Indianapolis, Indiana
  • +3 more
Feb 14, 2022

Leukemia Trial in Houston (Eltrombopag, Hypomethylating Agent (HMA))

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 5, 2020

Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Venetoclax plus Azacitidine
  • standard of care chemotherapy plus gemtuzumab ozogamicin
  • Essen, NRW, Germany
  • +17 more
Jun 6, 2023

Microsatellite Stable Colorectal Carcinoma, Platinum Resistant Epithelial Ovarian Cancer Type II, Estrogen Receptor Positive and

Completed
  • Microsatellite Stable Colorectal Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Mar 30, 2021

Refractory Colorectal Carcinoma, Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8 Trial in Houston

Recruiting
  • Refractory Colorectal Carcinoma
  • +8 more
  • Best Practice
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 24, 2021

MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2023